<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">
<html><body><html><body><section class="summaryOfFindings"><div class="section-header section-collapse-header" id="CD010514-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"><div class="section-header" id="CD010514-sec-0022"></div> <div class="table" id="CD010514-tbl-0001"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings for the main comparison.</span><span class="table-title"></span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="table-header separated">
<td align="" valign="" colspan="7" rowspan="1" class="table-header"> <p><b>Triclosan/copolymer/fluoride toothpaste compared with control for oral health</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> adults (children in 2 studies) </p> <p><b>Settings:</b> clinical (schools in 2 studies) </p> <p><b>Intervention:</b> triclosan/copolymer/fluoride toothpaste </p> <p><b>Comparison:</b> control toothpaste (no triclosan/copolymer) </p> </td> </tr>
<tr class="table-header separated">
<td align="" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Number of participants<br> (studies)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="" valign="" colspan="1" rowspan="3" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Assumed risk</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Corresponding risk</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Control</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Triclosan/copolymer</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Plaque at 6 to 7 months (QuigleyâHein Plaque Index)</b> </p> <p>(0 to 5 on an increasing scale)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean plaque score for the control groups was <b>2.17</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean plaque in the intervention groups was<br><b>0.47 lower</b><br> (0.60 to 0.34 lower) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2675<br> (20 studies) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br><b>moderate</b><sup>a</sup></p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>This evidence was supported by the results using the <b>Plaque Severity Index</b> (proportion of surfaces scoring &gt; 3 on the QuigleyâHein Plaque Index) at 6 to 7 months </p> <p>The mean plaque severity in the intervention groups was <b>0.15 lower</b> (0.20 to 0.10 lower) than the control group mean score of <b>0.37</b>. These results were based on 1850 analysed participants in 13 studies and we assessed the quality of the evidence (GRADE) as: </p> <p>ââââ<br><b>moderate</b><sup>a</sup></p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Gingivitis at 6 to 9 months (LÃ¶eâSilness Gingival Index)</b> </p> <p>(0 to 3 on an increasing scale)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean gingivitis score for the control groups was <b>1.22</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean gingivitis in the intervention groups was<br><b>0.27 lower</b><br> (0.33 to 0.21 lower) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2743<br> (20 studies) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br><b>moderate</b><sup>a</sup></p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>This evidence was supported by the results using the <b>Gingivitis Severity Index</b> (proportion of sites bleeding, i.e. 2 or 3 on the LÃ¶eâSilness Gingival Index) at 6 to 7 months </p> <p>The mean gingival bleeding in the intervention groups was <b>0.13 lower</b> (0.17 to 0.08 lower) than the control group mean score of <b>0.27</b>. These results were based on 1998 analysed participants in 15 studies and we assessed the quality of the evidence (GRADE) as: </p> <p>ââââ<br><b>moderate</b><sup>a</sup></p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Periodontitis at 36 months (attachment loss &gt; 0 mm)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>249 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>229 per 1000</b><br> (167 to 316) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 0.92</b> </p> <p>(0.67 to 1.27)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>480<br> (1 study) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br><b>low</b><sup>b</sup></p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Coronal caries increment at 24 to 36 months (decayed filled surfaces â DFS)</b> </p> <p>(caries increment is the change from baseline to followâup)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean DFS score for the control groups was <b>3.44</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean DFS in the intervention groups was<br><b>0.16 lower</b> <br> (0.31 to 0.02 lower) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9692<br> (4 studies) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br><b>high</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The mean increment of the <b>decayed filled teeth (DFT) index</b> at 30 to 36 months in the intervention groups was <b>0.06 lower</b> (0.14 lower to 0.02 higher) than the control group mean score of <b>1.63</b>. These results were based on 6300 analysed participants in 3 studies and we assessed the quality of the evidence (GRADE) as: </p> <p>ââââ<br><b>high</b> </p> <p>For root caries, the mean increment of the <b>Katz Root Caries Index</b> at 36 months in the intervention group was <b>0.31 lower</b> (0.39 to 0.23 lower) than the control group mean score of <b>0.38</b>. These results were based on 1357 analysed participants in 1 study and we assessed the quality of the evidence (GRADE) as: </p> <p>ââââ<br><b>moderate</b><sup>c</sup></p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Calculus at 6 months (VolpeâManhold Calculus Index in mm â mean total calculus per participant)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean calculus score for the control groups was <b>14.61</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean calculus in the intervention groups was<br><b>2.12 lower</b><br> (3.39 to 0.84 lower) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>415<br> (2 studies) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br><b>low</b><sup>d</sup></p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse effects</b> </p> </td> <td align="" valign="top" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>22 studies reported that there were no adverse effects in either the experimental or control arm of the study. 1 study reported mild adverse effects but not by group/arm. The remaining 7 studies did not report any information on adverse effects </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>These 4 metaâanalyses all had very high heterogeneity (I<sup>2</sup> &gt; 90%), however, we only downgraded by 1 point due to the consistency of the effects favouring triclosan/copolymer. The downgrading for was due to the prediction intervals slightly overlapping 0 (the line of no effect).<br><sup>b</sup>Single study at high risk bias with 95% CI including both an effect favouring the intervention and the control.<br><sup>c</sup>Single study (but with large sample size) at high risk bias.<br><sup>d</sup>2 studies (1 at high and 1 at unclear risk of bias) with high heterogeneity (I<sup>2</sup> = 91%). </p> </div> </td> </tr></tfoot>
</table>
</div> </section></section></body></html></body></html>
